Studies have shown that active fund managers routinely underperform the S&P500 index*​

Tempest Therapeutics, Inc. (NASDAQ: TPST)

TPST Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
333.10%

TPST Stock Analysis

TPST PE Ratio:

TPST PEG Ratio: Not Available

TPST Forward EPS Growth (12 month): 0.00%

TPST PS Ratio:

TPST PSG Ratio: Not Available

TPST Forward Revenue Growth (12 month): 0.00%

TPST Articles

No data was found